Skip to main content

New Products

  • Suja Elements non-GMO smoothies hit store shelves at Whole Foods nationwide

    SAN DIEGO — Suja Co., known for its fresh fruit and vegetable juices, is extending into the fresh smoothie category with the introduction of Suja Elements.

  • FDA approves Perrigo angina pectoris drug

    ALLEGAN, Mich. — The Food and Drug Administration has approved a drug made by Perrigo Co. for treating heart disease, the company said Monday.

    The FDA approved Perrigo's nitroglycerin lingual spray in the 400-mcg-per-spray strength. The drug is used to relieve attacks of or prevent angina pectoris due to coronary artery disease.

  • Sandoz launches authorized generic drug for myelodysplastic syndrome

    PRINCETON, N.J. — Sandoz has launched an authorized generic drug for treating a disease commonly known as pre-leukemia, the company said on Monday.

  • St. Joseph Rapid Dissolving Melts awarded 'Best New Product'

     PALM BEACH GARDENS, Fla. — St. Joseph Health Products was honored with "Best New Product" distinction here by retailers attending the ECRM Health Care EPPS. 

    The new product is St. Joseph Rapid Dissolving Melts low-dose aspirin, a new delivery format that will hold appeal among pill-phobic seniors looking to take a low-dose aspirin daily for heart health. 

  • Jack Link's introduces new limited-edition, globally-inspired snacks

    MINONG, Wis. — Jack Link's announced this month two new limited-edition snacks that draw inspiration from global cuisines in Southeast Asia and Latin America.

    Jack Link's new Sriracha beef and Burrito beef jerky are the latest additions to the Jack Link's line of meat snacks.

  • Teva launches generic niacin extended-release tablets

    JERUSALEM — Teva Pharmaceutical Industries has launched a generic drug for treating cardiovascular disease, the company said.

    Teva announced the launch of niacin extended-release tablets in the 500-mg, 750-mg and 1,000-mg strengths. As the first company to file for approval of the drug, Teva will have 180 days in which to market the generic version exclusively.

  • FDA to take 'tailored policy' to mobile medical app regulation

    SILVER SPRING, Md. — The Food and Drug Administration will not enforce regulatory requirements for most mobile medical apps because they "post minimal risk to consumers," the agency said Monday.

    The FDA announced the issuance of guidance on the apps, saying it would adopt a "tailored policy" toward regulation, focusing its regulatory oversight on those apps that present greater risk if they do not work as intended.

  • MusclePharm launching line developed by Arnold Schwarzenegger into GNC

    DENVER — MusclePharm on Monday announced that its Arnold Series, a new line of nutritional supplements developed by Arnold Schwarzenegger, will launch today on GNC.com and on Oct. 1, in GNC stores.

X
This ad will auto-close in 10 seconds